Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

MEDI vs QAAGZX overlap: 44% of top holdings shared

Bottom line

How much do MEDI and QAAGZX overlap?

44% of their top holdings overlap by weight. 10 securities appear in both funds' top 25, making up 42.4% of MEDI's assets and 40.1% of QAAGZX's. They share a meaningful core but differ in the rest of the portfolio.

QAAGZX holds far more positions (277 vs 44), so it is broader beyond the top names.

Updated Nov 22, 2026

Overlap at a glance

MEDIQAAGZX
Weight overlap (top 25)44%
Shared holdings10
Weight in shared holdings42.4%40.1%
Total positions44277
Expense ratio0.8%0.86%
Holdings as ofJul 31, 2026Jun 30, 2026

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Holdings MEDI and QAAGZX have in common

Holding% of MEDI% of QAAGZXOverlap
Eli Lilly & Co20.78%14.06%14.06%
Gilead Sciences Inc5.10%2.79%2.79%
AbbVie Inc3.09%5.12%3.09%
Intuitive Surgical Inc2.83%1.89%1.89%
Merck & Co Inc2.47%4.00%2.47%
Natera Inc2.26%1.44%1.44%
Danaher Corp1.73%1.44%1.44%
Guardant Health Inc1.54%1.22%1.22%
UnitedHealth Group Inc1.39%5.88%1.39%
Vertex Pharmaceuticals Inc1.22%2.26%1.22%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in MEDI

  1. Ascendis Pharma A/S — 13.61%
  2. Rhythm Pharmaceuticals Inc — 4.02%
  3. Cencora Inc — 2.75%
  4. Revolution Medicines Inc — 2.54%
  5. Insmed Inc — 2.52%
  6. Boston Scientific Corp — 2.40%
  7. Abivax SA — 2.16%
  8. Insulet Corp — 2.10%
  9. Argenx SE — 2.07%
  10. Vaxcyte Inc — 2.06%
  11. McKesson Corp — 2.02%
  12. Legend Biotech Corp — 1.91%
  13. Novo Nordisk A/S — 1.46%
  14. IDEXX Laboratories Inc — 1.40%
  15. PTC Therapeutics Inc — 1.31%

Only in QAAGZX

  1. Johnson & Johnson — 6.64%
  2. Thermo Fisher Scientific Inc — 2.53%
  3. Bristol-myers Squibb Co — 2.12%
  4. Abbott Laboratories — 1.91%
  5. Amgen Inc — 1.80%
  6. Stryker Corp — 1.78%
  7. Elevance Health Inc — 1.54%
  8. Cardinal Health Inc — 1.04%
  9. Royalty Pharma Plc- Cl A — 0.97%
  10. Tenet Healthcare Corp — 0.94%
  11. Cvs Health Corp — 0.93%
  12. Kymera Therapeutics Inc — 0.89%
  13. T. Rowe Price Government Reserve Fund — 0.87%
  14. Protagonist Therapeutics Inc — 0.85%
  15. Moderna Therapeutics Inc — 0.83%

Asset mix

Asset typeMEDIQAAGZX
Stocks99.6%96.9%
Preferred stock—2.2%
Cash & short-term funds—0.9%
Bonds—0.1%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Country mix

CountryMEDIQAAGZX
US76.7%92.3%
DK15.1%0.7%
NL2.6%1.0%
FR2.5%0.3%
KY1.9%0.5%
GB—1.8%
IE—0.8%
BM—0.7%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Check another pair

FAQ

How much do MEDI and QAAGZX overlap?
About 44% by weight. 10 securities appear in both funds' top 25 holdings; they make up 42.4% of MEDI's assets and 40.1% of QAAGZX's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do MEDI and QAAGZX have in common?
The largest shared holdings are Eli Lilly & Co, AbbVie Inc, Gilead Sciences Inc, Merck & Co Inc, Intuitive Surgical Inc.
Should I own both MEDI and QAAGZX?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, MEDI or QAAGZX?
QAAGZX is broader, with 277 positions versus 44 for MEDI. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.